Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma

Rogers, JE; Yamashita, K; Sewastjanow-Silva, M; Vicentini, ER; Waters, R; Ajani, JA

Ajani, JA (通讯作者),Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol 1, Houston, TX 77030 USA.

EXPERT REVIEW OF ANTICANCER THERAPY, 2023; 23 (6): 565

Abstract

IntroductionEsophageal cancers continue to confer a dismal prognosis. Targeted and immune therapies have skyrocketed in the world of cancer management......

Full Text Link